Stephen Thomas
Direktor/Vorstandsmitglied bei ELIEM THERAPEUTICS, INC.
Vermögen: 801 123 $ am 31.05.2024
Aktive Positionen von Stephen Thomas
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 27.06.2024 | - |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Gründer | 07.07.2017 | - |
Karriereverlauf von Stephen Thomas
Statistik
International
| Vereinigte Staaten | 2 |
| 2 |
Operativ
| Founder | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
| Eliem Therapeutics, Inc. |
- Börse
- Insiders
- Stephen Thomas
- Erfahrung
